Top

Intensive Care Medicine

Published in:

01-06-2004 | Original

Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units

Authors: Elisabeth Meyer, Frank Schwab, Daniel Jonas, Henning Rueden, Petra Gastmeier, Franz D. Daschner

Published in: Intensive Care Medicine | Issue 6/2004

Abstract

Objective

To study antimicrobial use for benchmarking and ensuring quality of antimicrobial treatment and to identify risk factors associated with the high use of antimicrobials in German intensive care units (ICUs) through implementation of the SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in ICUs) system.

Design

Prospective, unit-based surveillance on antimicrobial use from February, 2000, until June, 2002. The data are standardised by use of the defined daily dose (DDD) for each antimicrobial defined by the WHO and by calculating use per 1000 patient days.

Setting

The data were obtained from 35 German ICUs and stratified by type of ICU (medical, surgical, interdisciplinary).

Results

To date, the project covers a total of 266,013 patient days in 744 reported ICU months and 354,356 DDDs. Mean antimicrobial use density (AD) was 1,332 DDD/1000 patient days and was correlated with length of stay. Penicillins with beta-lactamase inhibitor (AD 338.3) and quinolones (155.5) were the antimicrobial group with the highest ADs. Comparison with US ICARE (Intensive Care Antimicrobial Resistance Epidemiology)/AUR (Antimicrobial Use and Resistance) data revealed a higher AD for glycopeptides and 3rd generation cephalosporins in ICARE/AUR ICUs, but a higher AD for carbapenems in German SARI ICUs regardless of the type of ICU. In the multivariate analysis, length of stay was an independent risk factor for an AD above the 75% percentile of the total amount of antimicrobials used (OR 1.96 per day); likewise, for the AD above the 75% percentile of carbapenems (OR 1.90 per day) and penicillins with extended spectrum (OR 2.01 per day). High use of glycopeptides and quinolones (AD >75% percentile) correlated with central venous catheter (CVC) rate (OR 1.14 per CVC day per 100 patient days and 1.16, respectively).

Conclusion

The SARI data on antimicrobials serve ICUs as a benchmark by which to improve the quality of antimicrobial drug administration and for international comparison.

Available only for authorised users

Anonymous (2001) Proposal for a council recommendation on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities L 34/13, 13502–13501

Gaynes R (1997) The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 11:757–765PubMed

Paladino JA (2000) Economic justification of antimicrobial management programs: implications of antimicrobial resistance. Am J Health Syst Pharm 57 (Suppl 2):S10–S12

Kollef MH, Fraser VJ (2001) Antibiotic resistance in the intensive care unit. Ann Intern Med 134:298–314

Weinstein RA (2001) Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis 7:188–192PubMed

Geffers C, Koch J, Sohr D, Nassauer A, Daschner F, Rueden H, Gastmeier P (2000) [Establishment of a national database for ICU-associated infections. First results from the “Krankenhaus-Infections-Surveillance-System” (KISS)]. Anaesthesist 49:732–737CrossRefPubMed

Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD (2003) Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31:208–215PubMed

ATC index with DDDs (1999) WHO Collaborating Centre for Drug Statistics Methodology, Oslo

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128–140PubMed

10.

National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 to June 2002 (2002) Am J Infect Control 30:458–475CrossRefPubMed

11.

National nosocomial infections surveillance (NNIS) system report. Data summary from January 1992 to June 2001 (2001) Am J Infect Control 29:404–421

12.

Gastmeier P, Schwab F, Geffers C, Rueden H (2002) Is the strict isolation of MRSA patients really necessary? Analysis of data from the German nosocomial infection surveillance system KISS. Fifth International Conference of the Hospital Infection Society, Edingbugh, abstact P5.03

13.

Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project intensive care antimicrobial resistance epidemiology (ICARE) hospitals. Clin Infect Dis 29:245–252PubMed

14.

Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, Isaksso B, Kahlmeter G, Lindgren S, Nilsson L, Olsson-Liljequist B, Hanberger H (2002) Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand 46:1075–1081CrossRefPubMed

15.

O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick, RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR 51:1–29

16.

Mertens R, Kegels G, Stroobant A, Reybrouck G, Lamotte JM, Potvliege C, Van Casteren V, Lauwers S, Verschraegen G, Wauters G (1987) The national prevalence survey of nosocomial infections in Belgium, 1984. J Hosp Infect 9:219–229PubMed

17.

Ruden H, Gastmeier P, Daschner FD, Schumacher M (1997) Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP). Infection 25:199–202PubMed

18.

Vaque J, Rossello J, Arribas JL (1999) Prevalence of nosocomial infections in Spain: EPINE study 1990–1997, EPINE Working Group. J Hosp Infect 43 (Suppl):S105–S111PubMed

19.

Sax H, Pittet D (2002) Interhospital differences in nosocomial infection rates: importance of case-mix adjustment. Arch Intern Med 162:2437–2442CrossRefPubMed

20.

OECD Health Data 2000 (2000) OECD, Paris

21.

Emmerson M (2000) Antibiotic usage and prescribing policies in the intensive care unit. Intensive Care Med 26 (Suppl 1):S26–S30CrossRefPubMed

Title: Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units
Authors: Elisabeth Meyer
Frank Schwab
Daniel Jonas
Henning Rueden
Petra Gastmeier
Franz D. Daschner
Publication date: 01-06-2004
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 6/2004
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-004-2266-9

2024 ASCO Annual Meeting

Springer Medicine

Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units

Abstract

Objective

Design

Setting

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Objective

Design

Setting

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2004

June 2004

Monitoring of respiratory variations of aortic blood flow velocity using esophageal Doppler

Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial

R3-Survey of traumatic brain injury management in European Brain IT centres year 2001

Cyclic changes in arterial pressure during mechanical ventilation

Gut barrier dysfunction as detected by intestinal luminal microdialysis